“LYMPHIR is an important new treatment option for the CTCL community, and its launch marks the beginning of a new chapter for ...
In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...
Blood Cancer United's new research funding supports foundational science, AI, big data and global collaborations to improve patient outcomes WASHINGTON, Dec. 2, 2025 /PRNewswire/ ...
Dave Coulier credits family, fans and co-stars for supporting his non-Hodgkin lymphoma recovery as he reveals a new cancer ...
23h
‘Shock to the system’: Dave Coulier shares new cancer diagnosis after beating non-Hodgkin lymphoma
Just months after sharing that he was cancer-free, “Full House” actor Dave Coulier says he has been diagnosed with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback